Skip to main content
Go to homepage

Grand Rounds: Gene-Based Therapeutics in Neuromuscular Disorders: The Future is Here!


By Kathryn Mosher, MD and Ian Rossman, MD, PhD , Sports Medicine Physician, Akron Children's Hospital, Akron, OH

Objectives (Educational Content) :

1. Tell the audience about the multidisciplinary neuromuscular clinic, who is an appropriate referral and how to refer. 2. Describe the clinical presentation of Duchenne Muscular Dystrophy, diagnosis, current treatment and future therapeutic strategies. 3. Explain the clinical presentation of spinal muscular atrophy, diagnosis, current treatment and future therapeutic strategies.

Target Audience:

General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists and nurses.

Identified Gap:

Newly developed strategic therapies will help to improve outcomes in the pediatric patient.

Estimated Time to Complete the Educational Activity:

1 hour

Expiration Date for CME Credit:


Method of Physician Participation in the Learning Process:

The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.

Evaluation Methods:

All learners must successfully complete a post-test, as well as an activity evaluation, to claim CME credit.

Accreditation Statement:

Children’s Hospital Medical Center of Akron is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

CHMCA designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.